Clinical trial
Male Hormonal Contraceptive Development-ACY-5
NCT00161447 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00161447 |
|---|---|
| Title | Male Hormonal Contraceptive Development-ACY-5 |
| Official title | Male Hormonal Contraceptive Development: Suppression of Spermatogenesis With the Addition of a Potent Antagonist (Acyline) to Testosterone and DMPA (ACY-5) |
| Acronym | ACY-5 |
| Lead sponsor | University of Washington, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH CONRAD |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Contraception |
| Intervention type | Drug |
| Interventions | Acyline, Testosterone Gel, Depo-Medroxyprogesterone |
| Enrollment | 43 |
| Start date | May 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 19, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: